Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial | Cancer Screening, Prevention, Control | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
Keys A. From Naples to seven countries—a sentimental journey.  Prog Biochem Pharmacol. 1983;19:1-306338519Google ScholarCrossref
2.
Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC. Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurses' Health Study.  Am J Epidemiol. 2005;161:672-67915781956Google ScholarCrossref
3.
Liu S, Stampfer MJ, Hu FB.  et al.  Whole grain consumption and risk of coronary heart disease: results from the Nurses' Health Study.  Am J Clin Nutr. 1999;70:412-41910479204Google Scholar
4.
Liu S, Manson JE, Lee I-M.  et al.  Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study.  Am J Clin Nutr. 2000;72:922-92811010932Google Scholar
5.
Fung TT, Stampfer MJ, Manson JE, Rexrode KM, Willett WC, Hu FB. Prospective study of major dietary patterns and stroke risk in women.  Stroke. 2004;35:2014-201915232120Google ScholarCrossref
6.
Kris-Etherton PM, Harris WS, Appel LJ.American Heart Association Nutrition Committee.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.  Circulation. 2002;21:2747-2757[published correction appears in Circulation. 2003;107:512].12438303Google ScholarCrossref
7.
Dayton S, Pearce ML, Hashimoto S, Cixon WJ, Tomlyasu U. A controlled trial of a diet high in unsaturated fat for preventing complications of atherosclerosis.  Circulation. 1969;60:(suppl 2)  111-163Google Scholar
8.
Leren P. The Oslo Diet-Heart Study: eleven year report.  Circulation. 1970;42:935-9425477261Google ScholarCrossref
9.
Turpeinen O, Karvonen MJ, Pekkarinen M, Miettinen M, Elosuo R, Paavilainen E. Dietary prevention of coronary heart disease: the Finnish Mental Hospital Study.  Int J Epidemiol. 1979;8:99-118393644Google ScholarCrossref
10.
de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.  Circulation. 1999;99:779-7859989963Google ScholarCrossref
11.
de Lorgeril M, Renaud S, Mamelle N.  et al.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.  Lancet. 1994;343:1454-1459[published correction appears in Lancet. 1995;345:738].7911176Google ScholarCrossref
12.
Ornish D, Scherwitz LW, Billings JH.  et al.  Intensive lifestyle changes for reversal of coronary heart disease.  JAMA. 1998;280:2001-20079863851Google ScholarCrossref
13.
Baigent C, Keech A, Kearney PM.  et al. Cholesterol Treatment Trialists’(CTT) Collaborators.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.  Lancet. 2005;366:1267-127816214597Google ScholarCrossref
14.
Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials.  JAMA. 1997;278:313-3219228438Google ScholarCrossref
15.
Women's Health Initiative Study Group.  Design of the Women's Health Initiative clinical trial and observational study.  Control Clin Trials. 1998;19:61-1099492970Google ScholarCrossref
16.
Ritenbaugh C, Patterson R, Chlebowski RT.  et al.  The Women's Health Initiative Dietary Modification Trial: overview and baseline characteristics of participants.  Ann Epidemiol. 2003;13:S87-S9714575941Google ScholarCrossref
17.
Patterson RE, Kristal A, Rodabough R.  et al.  Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative.  J Am Diet Assoc. 2003;103:454-46012669007Google Scholar
18.
Tinker LF, Burrows ER, Henry H, Patterson R, Rupp J, Van Horn L. The Women's Health Initiative: overview of the nutrition components. In: Krummel D, Kris-Etherton P, eds. Nutrition in Women's Health. Gaithersburg, Md: ASPEN Publishers; 1996:510-542
19.
Bowen D, Ehret C, Pedersen M.  et al.  Results of an adjunct dietary intervention program in the Women's Health Initiative.  J Am Diet Assoc. 2002;102:1631-163712449286Google ScholarCrossref
20.
US Department of Agriculture.  Dietary Guidelines for Americans. 3rd ed. Washington, DC: US Dept of Health and Human Services; 1990
21.
Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants.  Ann Epidemiol. 2003;13:(9 suppl)  S78-S8614575940Google ScholarCrossref
22.
Jackson RD, LaCroix AZ, Cauley JA, McGowan J. The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants.  Ann Epidemiol. 2003;13:(9 suppl)  S98-S10614575942Google ScholarCrossref
23.
Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Argus-Collins T. Measurement characteristics of the Women's Health Initiative food frequency questionnaire.  Ann Epidemiol. 1999;9:178-18710192650Google ScholarCrossref
24.
Writing Group for the Women's Health Initiative Investigators.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.  JAMA. 2002;288:321-33312117397Google ScholarCrossref
25.
Manson JE, Hsia J, Johnson KC.  et al. Women's Health Initiative Investigators.  Estrogen plus progestin and risk of CHD.  N Engl J Med. 2003;349:523-53412904517Google ScholarCrossref
26.
Curb JD, McTiernan A, Heckbert SR.  et al.  Outcomes ascertainment and adjudication methods in the Women's Health Initiative.  Ann Epidemiol. 2003;13:S122-S12814575944Google ScholarCrossref
27.
Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials.  Arterioscler Thromb. 1992;12:911-9181386252Google ScholarCrossref
28.
Prentice RL, Caan B, Chlebowski R.  et al.  Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative randomized controlled dietary modification trial.  JAMA. 2006;295:629-642Google ScholarCrossref
29.
Howard BV, Manson JE, Stefanick ML.  et al.  Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial.  JAMA. 2006;295:39-4916391215Google ScholarCrossref
30.
Matthews DR, Hosker JP, Rudenski AS.  et al.  Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;28:412-4193899825Google ScholarCrossref
31.
Beresford SAA, Johnson KC, Rittenbaugh C.  et al.  Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative randomized controlled dietary modification trial.  JAMA. 2006;295:643-654Google ScholarCrossref
32.
Krauss RM, Eckel RH, Howard B.  et al.  AHA Dietary Guidelines, Revision 2000: a statement for healthcare professionals from the nutrition committee of the American Heart Association.  Circulation. 2000;102:2284-229911056107Google ScholarCrossref
33.
Franz MJ, Bantle JP, Beebe CA, Brunzeu JD, Chasson JL. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications.  Diabetes Care. 2002;25:148-19811772915Google ScholarCrossref
34.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.  Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).  JAMA. 2001;285:2486-249711368702Google ScholarCrossref
35.
Pereira MA, Liu S. Types of carbohydrates and risk of cardiovascular disease.  J Womens Health (Larchmt). 2003;12:115-12212737710Google ScholarCrossref
36.
Hellerstein MK. Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk.  Curr Opin Lipidol. 2002;13:33-4011790961Google ScholarCrossref
37.
 Low-fat diet in myocardial infarction: a controlled trial.  Lancet. 1965;2:501-5044158171Google Scholar
38.
 Controlled trial of soya-bean oil in myocardial infarction.  Lancet. 1968;2:693-7004175085Google Scholar
39.
Watts GF, Lewis B, Brunt JNH.  et al.  Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St. Thomas' Atherosclerosis Regression Study (STARS).  Lancet. 1992;339:563-5691347091Google ScholarCrossref
40.
Chanmugam P, Guthrie JF, Cecilio S, Morton JF, Basiotis P, Anand R. Did fat intake in the United States really decline between 1989-1991 and 1994-1996?  J Am Diet Assoc. 2003;103:867-87212830026Google ScholarCrossref
41.
Subar AF, Kipnis V, Troiano RP.  et al.  Using intake of biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: the OPEN Study.  Am J Epidemiol. 2003;158:1-1312835280Google ScholarCrossref
42.
Wang C-Y, Anderson GL, Prentice RL. Estimation of the correlation between nutrient intake measures under restricted sampling.  Biometrics. 1999;55:711-71711314997Google ScholarCrossref
Original Contribution
February 8, 2006

Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial

Author Affiliations
 

Author Affiliations: MedStar Research Institute/Howard University, Washington, DC (Dr Howard); Northwestern University, Chicago/Evanston, Ill (Drs Horn and Greenland); George Washington University, Washington, DC (Dr Hsia); Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (Dr Manson); Stanford Prevention Research Center, Stanford, Calif (Dr Stefanick); Albert Einstein College of Medicine, Bronx, NY (Dr Wassertheil-Smoller); University of Pittsburgh, Pittsburgh, Pa (Dr Kuller); Fred Hutchinson Cancer Research Center, Seattle, Wash (Drs LaCroix, Prentice, Tinker, Anderson, and Beresford); University of California at San Diego (Dr Langer); University of Medicine and Dentistry of New Jersey, Newark (Dr Lasser); University of Alabama at Birmingham (Dr Lewis); University of Florida, Gainesville (Drs Limacher and Perri); University of Minnesota, Minneapolis (Dr Margolis); The Ohio State University, Columbus (Dr Mysiw); University of Massachusetts/Fallon Clinic, Worcester (Dr Ockene); University of Miami, Miami, Fla (Dr Parker); Emory University, Atlanta, Ga (Dr Phillips); University of California at Davis (Dr Robbins); National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Rossouw); University of Wisconsin, Madison (Dr Sarto); University of Hawaii, Honolulu (Dr Schatz); University of Iowa, Iowa City/Davenport (Dr Snetselaar); Kaiser Permanente Center for Health Research, Portland, Ore (Dr Stevens); University at Buffalo, Buffalo, NY (Dr Trevisan); Wake Forest University School of Medicine, Winston-Salem, NC (Dr Vitolins); Brown University, Providence, RI (Dr Assaf); University of Arizona, Tucson/Phoenix (Dr Bassford); Rush University Medical Center, Chicago (Dr Black); University of Nevada, Reno (Dr Brunner); University of Texas Health Science Center, San Antonio (Dr Brzyski); Kaiser Permanente Division of Research, Oakland, Calif (Dr Caan); Harbor-UCLA Research and Education Institute, Torrance, Calif (Dr Chlebowski); University of Cincinnati, Cincinnati, Ohio (Dr Gass); State University of New York at Stony Brook (Dr Granek); Baylor College of Medicine, Houston, Tex (Dr Hays); University of California at Los Angeles (Dr Heber); University of North Carolina, Chapel Hill (Dr Heiss); Wayne State University School of Medicine/Hutzel Hospital, Detroit, Mich (Dr Hendrix); University of California at Irvine (Dr Hubbell); University of Tennessee Health Science Center, Memphis (Dr Johnson); and Medical College of Wisconsin, Milwaukee (Dr Kotchen). Dr Assaf is now affiliated with Pfizer Inc, Cambridge, Mass.

JAMA. 2006;295(6):655-666. doi:10.1001/jama.295.6.655
Abstract

Context Multiple epidemiologic studies and some trials have linked diet with cardiovascular disease (CVD) prevention, but long-term intervention data are needed.

Objective To test the hypothesis that a dietary intervention, intended to be low in fat and high in vegetables, fruits, and grains to reduce cancer, would reduce CVD risk.

Design, Setting, and Participants Randomized controlled trial of 48 835 postmenopausal women aged 50 to 79 years, of diverse backgrounds and ethnicities, who participated in the Women's Health Initiative Dietary Modification Trial. Women were randomly assigned to an intervention (19 541 [40%]) or comparison group (29 294 [60%]) in a free-living setting. Study enrollment occurred between 1993 and 1998 in 40 US clinical centers; mean follow-up in this analysis was 8.1 years.

Intervention Intensive behavior modification in group and individual sessions designed to reduce total fat intake to 20% of calories and increase intakes of vegetables/fruits to 5 servings/d and grains to at least 6 servings/d. The comparison group received diet-related education materials.

Main Outcome Measures Fatal and nonfatal coronary heart disease (CHD), fatal and nonfatal stroke, and CVD (composite of CHD and stroke).

Results By year 6, mean fat intake decreased by 8.2% of energy intake in the intervention vs the comparison group, with small decreases in saturated (2.9%), monounsaturated (3.3%), and polyunsaturated (1.5%) fat; increases occurred in intakes of vegetables/fruits (1.1 servings/d) and grains (0.5 serving/d). Low-density lipoprotein cholesterol levels, diastolic blood pressure, and factor VIIc levels were significantly reduced by 3.55 mg/dL, 0.31 mm Hg, and 4.29%, respectively; levels of high-density lipoprotein cholesterol, triglycerides, glucose, and insulin did not significantly differ in the intervention vs comparison groups. The numbers who developed CHD, stroke, and CVD (annualized incidence rates) were 1000 (0.63%), 434 (0.28%), and 1357 (0.86%) in the intervention and 1549 (0.65%), 642 (0.27%), and 2088 (0.88%) in the comparison group. The diet had no significant effects on incidence of CHD (hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.90-1.06), stroke (HR, 1.02; 95% CI, 0.90-1.15), or CVD (HR, 0.98; 95% CI, 0.92-1.05). Excluding participants with baseline CVD (3.4%), the HRs (95% CIs) for CHD and stroke were 0.94 (0.86-1.02) and 1.02 (0.90-1.17), respectively. Trends toward greater reductions in CHD risk were observed in those with lower intakes of saturated fat or trans fat or higher intakes of vegetables/fruits.

Conclusions Over a mean of 8.1 years, a dietary intervention that reduced total fat intake and increased intakes of vegetables, fruits, and grains did not significantly reduce the risk of CHD, stroke, or CVD in postmenopausal women and achieved only modest effects on CVD risk factors, suggesting that more focused diet and lifestyle interventions may be needed to improve risk factors and reduce CVD risk.

Clinical Trials Registration ClinicalTrials.gov Identifier: NCT00000611

×